Yuhan Corporation

Beta

KRX Filings & Disclosures 2026

Risk Factors

• • KRW 7.65B pre-tax income sensitivity to 10% KRW FX rate increase at FY2025 end, up from KRW 6.72B in prior year
• • Largest equity investment price risk KRW 62.78B market value, with ±KRW 4.83B post-tax equity impact at FY2025 end

Management Discussion & Analysis

• • Revenue KRW 2.19T (+5.7% YoY), operating profit KRW 104.4B (+90.2%), net income KRW 185.3B (+235.9%) in FY2025
• • Overseas business revenue grew 26.1% YoY to KRW 386.6B led by increased exports of AIDS and Hepatitis C raw materials

Business Overview

• • Pharmaceutical business sales KRW 1.40T in FY2025, +3.5% driven by innovation drug Lekraza and new improved drugs lineup
• • Lekraza EGFR-targeted NSCLC drug global commercialization with multi-region approvals: US FDA Aug 2024, EU EC Jan 2025, Japan PMDA Mar 2025, China NMPA Jul 2025

What are the latest Yuhan Corporation DART filings in 2026?

Yuhan Corporation (KRX code 000100) has filed an annual report on March 12, 2026 with DART. SignalX tracks every new DART disclosure with AI-powered English summaries of business overview, risk factors, and management discussion.

When did Yuhan Corporation file its most recent annual report?

Yuhan Corporation filed its most recent annual report on March 12, 2026. The annual report includes audited financial statements, business overview, risk factors, and management discussion (MD&A), all available on SignalX with AI-generated English summaries and KIFRS financial data.

What is Yuhan Corporation's KRX stock code?

Yuhan Corporation's KRX stock code is 000100. The 6-digit stock code is the KRX standard identifier for every listed security. You can use stock code 000100 to look up all Yuhan Corporation disclosures on DART, or browse them here on SignalX with AI-powered English analysis.

How often does Yuhan Corporation file with DART?

Korean listed companies file an annual report once per year (typically within 90 days of fiscal year-end), a half-year report once mid-year, and quarterly reports for Q1 and Q3 — three regular periodic disclosures plus the annual. Material event reports are filed as needed when corporate events occur. SignalX monitors DART daily.

What is the difference between annual, half-year, and quarterly reports in Korea?

An annual report is a comprehensive filing with audited financials, business overview, and risk factors — analogous to the US 10-K. A half-year (interim) report covers H1 results. Quarterly reports cover Q1 or Q3 — analogous to the US 10-Q but Korea publishes only two quarterly reports per year (with the half-year report covering Q2). SignalX provides AI-generated English summaries for all three filing types for Yuhan Corporation.

Where can I find Yuhan Corporation financial data and KIFRS metrics?

SignalX extracts KIFRS consolidated financial data from Yuhan Corporation annual reports, including revenue, gross profit, operating income, net income, total assets, stockholders' equity, EPS (basic/diluted), operating cash flow, and capital expenditure — all in KRW. Multi-year financial trends are displayed in the Financial Summary table above.